BR0200377A - Formulações multiparticuladas de sais de lìtio para ministraçào oral apropriadas para ministração uma vez ao dia - Google Patents

Formulações multiparticuladas de sais de lìtio para ministraçào oral apropriadas para ministração uma vez ao dia

Info

Publication number
BR0200377A
BR0200377A BR0200377-5A BR0200377A BR0200377A BR 0200377 A BR0200377 A BR 0200377A BR 0200377 A BR0200377 A BR 0200377A BR 0200377 A BR0200377 A BR 0200377A
Authority
BR
Brazil
Prior art keywords
lithium salts
once daily
administration
oral administration
multiparticulate formulations
Prior art date
Application number
BR0200377-5A
Other languages
English (en)
Inventor
Roberto Valducci
Tiziano Alighieri
Serozh Avanessian
Original Assignee
Valpharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valpharma Sa filed Critical Valpharma Sa
Publication of BR0200377A publication Critical patent/BR0200377A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"FORMULAçõES MULTIPARTICULADAS DE SAIS DE LìTIO PARA MINISTRAçãO ORAL APROPRIADAS PARA MINISTRAçãO UMA VEZ AO DIA". A presente invenção se refere à formulações multiparticuladas de sais de Lítio para ministração oral constituída ou por grânulos de liberação modificada ou misturas de grânulos de liberação modificada e convencional, adequadas para a ministração uma vez ao dia, também com altas concentrações de sais de Lítio. A presente invenção também se refere ao processo de preparação das mencionadas formulações.
BR0200377-5A 2001-02-05 2002-02-05 Formulações multiparticuladas de sais de lìtio para ministraçào oral apropriadas para ministração uma vez ao dia BR0200377A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000220A ITMI20010220A1 (it) 2001-02-05 2001-02-05 Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno

Publications (1)

Publication Number Publication Date
BR0200377A true BR0200377A (pt) 2002-10-15

Family

ID=11446743

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0200377-5A BR0200377A (pt) 2001-02-05 2002-02-05 Formulações multiparticuladas de sais de lìtio para ministraçào oral apropriadas para ministração uma vez ao dia

Country Status (8)

Country Link
US (2) US6994873B2 (pt)
EP (1) EP1228763A1 (pt)
JP (1) JP2002284694A (pt)
AU (1) AU782030B2 (pt)
BR (1) BR0200377A (pt)
CA (1) CA2370355A1 (pt)
IT (1) ITMI20010220A1 (pt)
NZ (1) NZ517053A (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1476138T1 (sl) 2002-02-21 2012-07-31 Valeant Internat Barbados Srl Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
ITFI20050215A1 (it) * 2005-10-13 2007-04-14 Valpharma Internat S P A Composizione nutrizionale a base di amminoacidi
NZ703464A (en) 2006-04-26 2016-05-27 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
DE102008017439A1 (de) * 2008-04-03 2009-10-08 Henkel Ag & Co. Kgaa Mittel zum Aufhellen von keratinhaltigen Fasern mit beschichteten Partikeln
US20120189693A1 (en) * 2009-06-25 2012-07-26 Elite Laboratories, Inc. Oral dosage forms
CN113521024A (zh) * 2017-04-17 2021-10-22 上海葆隆生物科技有限公司 一种碳酸锂缓释片
US20210378976A1 (en) * 2018-01-19 2021-12-09 University Of Georgia Research Foundation, Inc. Lithium fluoride nanoparticles for the protection of chondrocytes in osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244485A1 (en) * 1973-08-06 1975-04-18 Aries Robert Lithium dicarboxylic acid salts - in compositions for treatment of psychoses, esp. manic depression
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
EP1315480B1 (en) * 2000-08-10 2005-05-11 Unihart Corporation "slow release" pharmaceutical compositions comprising lithium carbonate
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same

Also Published As

Publication number Publication date
US20020172727A1 (en) 2002-11-21
US6994873B2 (en) 2006-02-07
AU782030B2 (en) 2005-06-30
AU1543702A (en) 2002-08-08
ITMI20010220A1 (it) 2002-08-05
EP1228763A1 (en) 2002-08-07
CA2370355A1 (en) 2002-08-05
JP2002284694A (ja) 2002-10-03
US20060039997A1 (en) 2006-02-23
NZ517053A (en) 2002-11-26

Similar Documents

Publication Publication Date Title
NO307495B1 (no) Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
SE0001899D0 (sv) New compounds
BR0010498A (pt) Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
BR0308814A (pt) Aminoácidos com afinidade para a proteìna-alfa2gama
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
DE60039291D1 (de) Camptothecinanaloge und deren zubereitungsmethoden
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
BR0200377A (pt) Formulações multiparticuladas de sais de lìtio para ministraçào oral apropriadas para ministração uma vez ao dia
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
BR0211063A (pt) Sais de derivados anticonvulsivantes
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
ATE422364T1 (de) Multivalente immunogenische zusammensetzung, die eine rsv untereinheit zusammensetzung und ein influenzavirus präparat enthält
ATE360428T1 (de) Analgetisches arzneimittel
AR001765A1 (es) Una formulación de liberación prolongada un procedimiento para su preparación una forma cristalina de cisaprida-(l)-tartrato y un medicamento util para el tratamiento de trastornos gastrointestinales
BRPI0414781A (pt) aminoácidos com afinidade para a proteìna (alfa)2(delta)
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
BR0010150A (pt) Solução oral de prucalopride
BR0312026A (pt) Microcápsulas para a liberação retardada e controlada do perindopril
BR0211223A (pt) Derivados de 4-aminociclohexanol substituìdos
BR0311878A (pt) Sais farmacêuticos de reboxetina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A A NUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.